Meeting
2017 ASCO Annual Meeting
KRAS in non-small cell lung cancer: Single institution experience—What factors are involved?
Authors
Idoroenyi Usua Amanam
City of Hope Comprehensive Cancer Center, Duarte, CA
Idoroenyi Usua Amanam , Rohan Gupta , Isa Mambetsariev , Marianna Koczywas , Mihaela C. Cristea , Erminia Massarelli , Karen L. Reckamp , Ravi Salgia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Other
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11624)
DOI
10.1200/JCO.2017.35.15_suppl.11624
Abstract #
11624
Poster Bd #
324
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
ECOG-ACRIN LUNG-MAP S1900E substudy: A phase II study of sotorasib in participants (Pts) with previously treated stage IV or recurrent KRAS G12C mutant non-squamous (Non-sq) non-small cell lung cancer (NSCLC).
First Author: Sukhmani Kaur Padda
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
First Author: Heng Tan
Poster
2022 ASCO Annual Meeting
Differential prognostic effect of systemic inflammation in patients with NSCLC treated with immunotherapy or chemotherapy: A post hoc analysis of the phase III OAK trial.
First Author: Alessio Cortellini
Poster
2022 ASCO Annual Meeting
The distribution of genetic mutations correlated with resistance to KRASG12C inhibitors in Chinese patients with lung cancer.
First Author: Shengcheng Lin